Ricardo Baptista

Chief Technology Officer • Alder Therapeutics

Ricardo Baptista has been working in Cell therapy Development and CMC globally, mostly managing teams designing bioprocessing and analytical platforms for the scalable manufacture of allogeneic cell therapies in companies as Procella Tx, Cellectis, CGT Catapult,  and CCRM. He was also involved in the generation and manufacture of clinical-grade iPSC lines, and the design of GMP facilities. Ricardo is a Biotechnology Engineer, obtained his PhD degree in Biotechnology and Biochemical Engineering at Instituto Superior Tecnico, Portugal, and post-doctoral studies at Peter Zandstra’s Stem Cell Bioengineering Lab.

Also Speaking

Donna Rill

Chief Technical Officer • Triumvira Immunologics

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies  • Novartis

Ohad Karneili

Chief Executive Officer • Adva Biotechnology

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.